Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis

Esophageal cancer (EC) is an aggressive malignancy with a poor prognosis. Various factors, including dietary habits, and antacid and antibiotic use, have been shown to influence the esophageal microbiome. Conversely, enrichment and diversity of the esophageal microbiome can also impact its function....

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Cancer Biology & Medicine
المؤلفون الرئيسيون: Yi Li, Bing Wei, Xia Xue, Hongle Li, Jun Li
التنسيق: مقال
اللغة:الإنجليزية
منشور في: China Anti-Cancer Association 2024-02-01
الموضوعات:
الوصول للمادة أونلاين:https://www.cancerbiomed.org/content/21/2/163
_version_ 1850049636264312832
author Yi Li
Bing Wei
Xia Xue
Hongle Li
Jun Li
author_facet Yi Li
Bing Wei
Xia Xue
Hongle Li
Jun Li
author_sort Yi Li
collection DOAJ
container_title Cancer Biology & Medicine
description Esophageal cancer (EC) is an aggressive malignancy with a poor prognosis. Various factors, including dietary habits, and antacid and antibiotic use, have been shown to influence the esophageal microbiome. Conversely, enrichment and diversity of the esophageal microbiome can also impact its function. Recent studies have revealed prevalent changes in the esophageal microbiome among patients with EC, thus suggesting the potential contribution of the esophageal microbiome to EC development. Additionally, distinct microbiome compositions have been observed in patients with different responses to radiotherapy and chemotherapy, indicating the role of the esophageal microbiome in modulating treatment outcomes. In this review, we have examined previous studies on the esophageal microbiome in healthy individuals and patients with EC or other esophageal diseases, with a focus on identifying microbial communities associated with EC pathogenesis and prognosis. Understanding the role of the microbiome in EC may aid in early detection and optimized treatment strategies, ultimately leading to better outcomes for patients.
format Article
id doaj-art-2e0662ef287c416c8335f0710cb9fb07
institution Directory of Open Access Journals
issn 2095-3941
language English
publishDate 2024-02-01
publisher China Anti-Cancer Association
record_format Article
spelling doaj-art-2e0662ef287c416c8335f0710cb9fb072025-08-20T00:27:30ZengChina Anti-Cancer AssociationCancer Biology & Medicine2095-39412024-02-0121216317410.20892/j.issn.2095-3941.2023.0177Microbiome changes in esophageal cancer: implications for pathogenesis and prognosisYi Li0Bing Wei1Xia Xue2Hongle Li3Jun Li4Department of Molecular Pathology, Clinical Pathology Center, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450003, ChinaDepartment of Molecular Pathology, Clinical Pathology Center, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450003, ChinaHenan Key Laboratory of Helicobacter pylori & Microbiota and Gastrointestinal Cancer, Marshall Medical Research Center, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, ChinaDepartment of Molecular Pathology, Clinical Pathology Center, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450003, ChinaDepartment of Molecular Pathology, Clinical Pathology Center, Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou 450003, ChinaEsophageal cancer (EC) is an aggressive malignancy with a poor prognosis. Various factors, including dietary habits, and antacid and antibiotic use, have been shown to influence the esophageal microbiome. Conversely, enrichment and diversity of the esophageal microbiome can also impact its function. Recent studies have revealed prevalent changes in the esophageal microbiome among patients with EC, thus suggesting the potential contribution of the esophageal microbiome to EC development. Additionally, distinct microbiome compositions have been observed in patients with different responses to radiotherapy and chemotherapy, indicating the role of the esophageal microbiome in modulating treatment outcomes. In this review, we have examined previous studies on the esophageal microbiome in healthy individuals and patients with EC or other esophageal diseases, with a focus on identifying microbial communities associated with EC pathogenesis and prognosis. Understanding the role of the microbiome in EC may aid in early detection and optimized treatment strategies, ultimately leading to better outcomes for patients.https://www.cancerbiomed.org/content/21/2/163esophageal cancermicrobiomedysbiosismicroenvironmentcarcinogenesis
spellingShingle Yi Li
Bing Wei
Xia Xue
Hongle Li
Jun Li
Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis
esophageal cancer
microbiome
dysbiosis
microenvironment
carcinogenesis
title Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis
title_full Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis
title_fullStr Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis
title_full_unstemmed Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis
title_short Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis
title_sort microbiome changes in esophageal cancer implications for pathogenesis and prognosis
topic esophageal cancer
microbiome
dysbiosis
microenvironment
carcinogenesis
url https://www.cancerbiomed.org/content/21/2/163
work_keys_str_mv AT yili microbiomechangesinesophagealcancerimplicationsforpathogenesisandprognosis
AT bingwei microbiomechangesinesophagealcancerimplicationsforpathogenesisandprognosis
AT xiaxue microbiomechangesinesophagealcancerimplicationsforpathogenesisandprognosis
AT hongleli microbiomechangesinesophagealcancerimplicationsforpathogenesisandprognosis
AT junli microbiomechangesinesophagealcancerimplicationsforpathogenesisandprognosis